Nonetheless, this data demonstrates a mechanism whereby infiltrating myleloid cells drive the tumour cell expression of LAMA5 through NfKB signalling to promote angiogenesis and thereby link two hallmarks of cancer progression—inflammation and angiogenesis—to ECM protein deposition, placing the regulation of laminin expression at the centre of these processes. The gene discussed is LAMA5; the disease is cancer.